Lv11
30 积分 2022-09-06 加入
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
1小时前
待确认
The current and emerging immunotherapy paradigm in small-cell lung cancer
1个月前
已完结
[Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance]
2个月前
已关闭
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs’ development
2个月前
已完结
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
4个月前
已完结
Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study
4个月前
已完结
Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study
4个月前
已完结
Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases
8个月前
已完结
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
9个月前
已完结
Imaging and Monitoring HER2 Expression in Tumors during HER2 Antibody–Drug Conjugate Therapy Utilizing a Radiolabeled Site-Specific Single-Domain Antibody Probe: 68Ga-NODAGA-SNA004-GSC
9个月前
已完结
皖公网安备34019202002308
